New aspects of the chemothrapy of bilharziasis with Ambilhar (Niridazole).
D000293:Adolescent; D000328:Adult; D000349:Africa; D001938:Brazil; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D004534:Egypt; D005500:Follow-Up Studies; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D009560:Niridazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010634:Phenobarbital / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D012548:Schistosoma haematobium / Q000187:drug effects; D012550:Schistosoma mansoni / Q000187:drug effects; D012552:Schistosomiasis / Q000188:drug therapy* / Q000469:parasitology; D012640:Seizures / Q000139:chemically induced
D010919:Placebos; D009560:Niridazole; D010634:Phenobarbital